Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants
ClinicalTrials.gov study NCT04812548. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02641002. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del
ClinicalTrials.gov study NCT00885508. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale
ClinicalTrials.gov study NCT01092936. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Allogeneic HSCT in MDS Patients Based on Risk According to R-IPSS
ClinicalTrials.gov study NCT04801563. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
ClinicalTrials.gov study NCT04477291. IPD Sharing: NO. Countries: 1. Publications: 2.
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
ClinicalTrials.gov study NCT05933070. IPD Sharing: NO. Countries: 2. Publications: 25.
Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells
ClinicalTrials.gov study NCT01355913. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Red Blood Cell Transfusion Thresholds and QOL in MDS
ClinicalTrials.gov study NCT02099669. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00280631. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients
ClinicalTrials.gov study NCT02477631. IPD Sharing: Not stated. Countries: 1. Publications: 15.
A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02966782. IPD Sharing: NO. Countries: 3. Publications: 2.
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01211457. IPD Sharing: NO. Countries: 1. Publications: 0.
Randomized Study of Haploidentical Hct and Subsequent Donor nk Cell Infusion in High-risk AML and MDS
ClinicalTrials.gov study NCT02477787. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
ClinicalTrials.gov study NCT00321711. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00443339. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
ClinicalTrials.gov study NCT00986804. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT
ClinicalTrials.gov study NCT02872662. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
ClinicalTrials.gov study NCT04730258. IPD Sharing: NO. Countries: 3. Publications: 1.
Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS
ClinicalTrials.gov study NCT02576301. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.